HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Lutz Selected Research

B Lutz Research Topics

Disease

2Glioma (Gliomas)
11/2019 - 10/2019
2Pain (Aches)
01/2019 - 09/2017
2Infections
10/2016 - 08/2016
2Obesity
10/2010 - 03/2003
2Inflammation (Inflammations)
06/2006 - 02/2006
2Colitis
06/2006 - 02/2006
1Neck Pain (Cervicalgia)
01/2019
1Abscess
10/2016
1Congenital Abnormalities (Deformity)
10/2016
1Periprosthetic Fractures
08/2016
1Osteolysis
08/2016
1Abdominal Aortic Aneurysm
12/2015
1Huntington Disease (Huntington's Disease)
10/2015
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2015
1Body Weight (Weight, Body)
10/2010
1Down Syndrome (Down's Syndrome)
12/2008
1Parkinson Disease (Parkinson's Disease)
12/2008
1Alzheimer Disease (Alzheimer's Disease)
12/2008
1Abdominal Obesity
04/2006
1HIV Infections (HIV Infection)
07/2004
1Feeding and Eating Disorders (Eating Disorder)
03/2003
1Acromegaly
06/2001
1Prolactinoma (Prolactinomas)
06/2001
1Pituitary Neoplasms (Pituitary Adenoma)
06/2001
1Adenoma (Adenomas)
06/2001
1Wilms Tumor (Wilm's Tumor)
04/2001
1Pathologic Constriction (Stenosis)
06/2000
1Hypertrophy
03/2000
1Erythema Nodosum
02/2000

Drug/Important Bio-Agent (IBA)

3EndocannabinoidsIBA
09/2017 - 06/2001
3CannabinoidsIBA
10/2010 - 06/2001
2Chemokine ReceptorsIBA
12/2015 - 07/2004
2Cannabinoid Receptor AntagonistsIBA
10/2010 - 03/2003
22,4-dinitrofluorobenzene sulfonic acidIBA
06/2006 - 02/2006
2RimonabantIBA
04/2006 - 06/2001
1Analgesics (Analgesic Drugs)IBA
01/2019
1Polyethylene (Polythene)IBA
08/2016
1LigandsIBA
12/2015
1Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2015
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
10/2015
1AM6545IBA
10/2010
1SeptinsIBA
12/2008
1alpha-SynucleinIBA
12/2008
1Guanosine Triphosphate (GTP)IBA
12/2008
1GTP Phosphohydrolases (GTPases)IBA
12/2008
1HydrolasesIBA
12/2008
1Dyrk KinasesIBA
12/2008
1AtropineFDA LinkGeneric
06/2006
1DinitrobenzenesIBA
02/2006
1Peroxidase (Myeloperoxidase)IBA
02/2006
1TRPV Cation ChannelsIBA
02/2006
1Sulfonic AcidsIBA
02/2006
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
06/2001
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2001
1Hormones (Hormone)IBA
06/2001
1Adrenocorticotropic Hormone (ACTH)FDA Link
06/2001
1Transcription Factors (Transcription Factor)IBA
04/2001
1Proteins (Proteins, Gene)FDA Link
04/2001
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2000
1Kainic Acid (Kainate)IBA
03/2000
1Thalidomide (Thalomid)FDA Link
02/2000

Therapy/Procedure

4Therapeutics
11/2019 - 03/2003
1Proton Therapy
10/2019
1Physical Therapy Modalities (Physical Therapy Technique)
01/2019
1Musculoskeletal Manipulations (Manipulative Therapy)
01/2019
1Analgesia
01/2019
1Debridement
10/2016
1Conservative Treatment
10/2016
1Decompression
10/2016
1Antibiotic Prophylaxis
10/2016
1Inlays (Inlay)
08/2016
1Hip Replacement Arthroplasty (Total Hip Replacement)
08/2016